40
Participants
Start Date
July 1, 2020
Primary Completion Date
December 31, 2024
Study Completion Date
June 30, 2025
BK CTL
"Patient with refractory BK infection and a HLA Matched Related Donors: BK specific CTLs (2.5 x 104 CD3/kg) infused intravenously on day 0 and may be additionally reinfused at a minimum of every two weeks (depending on safety and efficacy) for a maximum of five total infusions (maximum 12.5 x 104 CD3/kg).~Patients with refractory BK virus and a HLA Mismatched Related Donors: BK specific CTLs (0.5x104 CD3/kg) infused intravenously on day 0 and may additionally be reinfused at a minimum of every two weeks (depending on safety and efficacy) for a maximum of five total infusions (maximum 2.5 x 104 CD3/kg)."
RECRUITING
New York Medical College, Valhalla
RECRUITING
Children's Hospital of Pennsylvania, Philadelphia
RECRUITING
Johns Hopkins, Baltimore
RECRUITING
Nationwide Children's Hosptial, Columbus
RECRUITING
Medical College of Wisconsin, Milwaukee
RECRUITING
Washington University, St Louis
RECRUITING
Children's Hospital of Colorado, Aurora
RECRUITING
University of California San Francisco, San Francisco
Lead Sponsor
Children's Hospital of Philadelphia
OTHER
Medical College of Wisconsin
OTHER
Nationwide Children's Hospital
OTHER
Johns Hopkins University
OTHER
University of California, San Francisco
OTHER
New York Medical College
OTHER